Gontero Romina Patricia, Bedoya María Eugenia, Benavente Emilio, Roverano Susana Graciela, Paira Sergio Oscar
Sección Reumatología, Hospital José María Cullen, Santa Fe, Argentina.
Sección Reumatología, Hospital José María Cullen, Santa Fe, Argentina.
Reumatol Clin. 2015 May-Jun;11(3):151-5. doi: 10.1016/j.reuma.2014.05.005. Epub 2014 Nov 22.
To define the proportion of osteonecrosis (ON) in our patient population with lupus and to identify factors associated with the development of ON in systemic lupus erythematosus, as well as to carry out a descriptive analysis of ON cases.
Observational retrospective study of 158 patients with SLE (ACR 1982 criteria). Demographic and laboratory data, clinical manifestations, SLICC, SLEDAI, cytotoxic and steroid treatments were compared. In patients with ON, we analyzed time of disease progression and age at ON diagnosis, form of presentation, joints involved, diagnostic methods, Ficat-Arlet classification, and treatment. To compare the means, t-test or Mann-Whitney's test were employed and the cHi-2 test or Fisher's exact test, as appropriate, were used to measure the equality of proportions.
ON was present in 15 out 158 patients (9.5%), 13 women and 2 men, with a mean age of 30 (r: 16-66) at diagnosis and 35 months of evolution until diagnosis (r: 1-195). Among the 15 patients, 34 joints presented ON, 23 were symptomatic and 22 were diagnosed by magnetic resonance images. Twenty-six occurred in hips (24 bilateral), 4 in knees and 4 in shoulders. In 13 patients, ON involved 2 or more joints. At onset, 28 joints were in stage i-ii, one in stage iii and 5 had no data and; in the end, 14 were in stage iii-iv, 5 in stage i-ii and 15 had no data. Twenty-nine underwent conservative treatment with rest and 8 hips required joint replacement. ON progression was associated with Cushing's syndrome (P=0.014) OR 4.16 (95% CI 1.4-12.6) and 2nd year SLICC (P=0.042). No relation with clinical manifestations, lab results, cytotoxic treatment, steroid treatment (total accumulated dose, mean daily dose and duration) metilprednisolone pulses, nor activity was found. All patients with ON received antimalarials, in contrast to 77% of those without ON.
The proportion of ON was 9.5%, mainly in women, 76% in hips (26) and 92% bilaterally. They were associated significantly with Cushing's syndrome and accumulated damage at second year.
确定狼疮患者群体中骨坏死(ON)的比例,识别系统性红斑狼疮中与ON发生相关的因素,并对ON病例进行描述性分析。
对158例符合美国风湿病学会1982年标准的系统性红斑狼疮(SLE)患者进行观察性回顾研究。比较人口统计学和实验室数据、临床表现、系统性红斑狼疮国际协作临床分类(SLICC)、系统性红斑狼疮疾病活动指数(SLEDAI)、细胞毒性药物和类固醇治疗情况。对于ON患者,我们分析了疾病进展时间和ON诊断时的年龄、表现形式、受累关节、诊断方法、菲卡特 - 阿莱特分类以及治疗情况。为比较均值,采用t检验或曼 - 惠特尼检验,酌情使用卡方检验或费舍尔精确检验来衡量比例的相等性。
158例患者中有15例(9.5%)发生ON,其中13例女性和2例男性,诊断时平均年龄为30岁(范围:16 - 66岁),从发病到诊断的病程为35个月(范围:1 - 195个月)。15例患者中,34个关节出现ON,23个有症状,22个通过磁共振成像诊断。26个发生在髋关节(24个双侧),4个在膝关节,4个在肩关节。13例患者中,ON累及2个或更多关节。发病时,28个关节处于I - II期,1个处于III期,5个无数据;最终,14个处于III - IV期,5个处于I - II期,15个无数据。29例接受了休息的保守治疗,8个髋关节需要关节置换。ON进展与库欣综合征(P = 0.014)或比值比4.16(95%可信区间1.4 - 12.6)以及第二年的SLICC(P = 0.042)相关。未发现与临床表现、实验室结果、细胞毒性治疗、类固醇治疗(总累积剂量、平均每日剂量和疗程)、甲泼尼龙冲击治疗以及疾病活动度有关。与未发生ON的患者中77%相比,所有ON患者均接受了抗疟药治疗。
ON的比例为9.5%,主要发生在女性中,76%(26个)累及髋关节,92%为双侧受累。它们与库欣综合征以及第二年的累积损伤显著相关。